Ge, L., Zhou, Y., Lou, Y., Ai, H., Mao, L., Wang, Q., Wu, H., Tong, H., Wei, X., Jin, J., Wang, H., Yin, Q. (2025). Efficacy of short-course versus standard-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2025-1562